A randomized, double-blind, placebo-controlled, phase II dose-finding study of the short acting β1-blocker, landiolol hydrochloride, in patients with suspected ischemic cardiac disease (Q37043285)
Jump to navigation
Jump to search
scientific article published on 20 June 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized, double-blind, placebo-controlled, phase II dose-finding study of the short acting β1-blocker, landiolol hydrochloride, in patients with suspected ischemic cardiac disease |
scientific article published on 20 June 2013 |
Statements
1 reference
A randomized, double-blind, placebo-controlled, phase II dose-finding study of the short acting β1-blocker, landiolol hydrochloride, in patients with suspected ischemic cardiac disease (English)
1 reference
Masahiro Jinzaki
1 reference
Masaharu Hirano
1 reference
Kazuhiro Hara
1 reference
Takahiko Suzuki
1 reference
Akira Yamashina
1 reference
Yuji Ikari
1 reference
Misako Iino
1 reference
Takuhiro Yamaguchi
1 reference
Sachio Kuribayashi
1 reference
20 June 2013
1 reference
1 reference
29 Suppl 1
1 reference
7-20
1 reference
1 June 2013
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference